SCHEMBL7520141

SCHEMBL7520141

Clc1cc2c(Cl)nc(-c3cnccn3)nc2s1.Clc1cc2c(NCc3ccc4c(c3)OCO4)nc(-c3cnccn3)nc2s1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.47
NPSR1 Q6W5P4 1/20 0.47
PDE5A O76074 7/20 0.42
MEN1 O00255 3/20 0.42
KMT2A Q03164 3/20 0.42
ALDH1A1 P00352 2/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
TSHR P16473 3/20 0.42
KDM4E B2RXH2 2/20 0.42
HSD17B10 Q99714 2/20 0.42
CYP1A2 P05177 1/20 0.42
CYP3A4 P08684 1/20 0.42
CYP2D6 P10635 1/20 0.42
CYP2C9 P11712 1/20 0.42
CYP2C19 P33261 1/20 0.42
CLK4 Q9HAZ1 6/20 0.41
USP1 O94782 1/20 0.41
WDR48 Q8TAF3 1/20 0.41
CLK1 P49759 3/20 0.40
CLK2 P49760 3/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5125618 0.97 MAPT (0.50) MAPTNPSR1PDE5AMEN1KMT2A
SCHEMBL7515049 0.92 BCDIN3D (0.41) MAPTNPSR1PDE5ATSHRKDM4E
SCHEMBL5114975 0.91 MAPT (0.44) MAPTNPSR1PDE5AMEN1KMT2A
SCHEMBL5122882 0.88 BCDIN3D (0.41) MAPTNPSR1PDE5AMEN1KMT2A
SCHEMBL7504877 0.87 MAPT (0.41) MAPTNPSR1PDE5AMEN1KMT2A
SCHEMBL7522686 0.86 MAPT (0.65) MAPTNPSR1PDE5AMEN1KMT2A
SCHEMBL5122159 0.86 MAPT (0.50) MAPTNPSR1PDE5AMEN1KMT2A
SCHEMBL5121879 0.86 MAPT (0.50) MAPTNPSR1PDE5AMEN1KMT2A
SCHEMBL5116032 0.85 USP1 (0.50) MAPTNPSR1PDE5AMEN1KMT2A
SCHEMBL5117960 0.84 USP1 (0.49) MAPTNPSR1PDE5AMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1998006722-A1 THIENOPYRIMIDINES MERCK PATENT GMBH (DE) 1998-02-19 WO disclosed